Comparative Anti Helicobacter Pylori Efficacy Assessment of Unani Formulation and Quintuple Regimen

NCT03837210 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

H.Pylori Infection

Interventions

DRUG: Pylorin

Sponsor

Hamdard University